Roche
Roche is a global innovative pharmaceutical and diagnostic company that uses cutting-edge science to improve people's lives.
Combining the pharmaceutical and diagnostic divisions allows Roche to be one of the leaders in the field of personalized medicine — a strategy aimed at developing effective medical solutions for patients, taking into account the individual characteristics of each.
-
127 million
Patients are treated with Rosh drugs in a year
-
23.4 billion
Tests conducted using the products of "Rosh diagnostics"
-
26
Roche drugs are included in the list of VED in Russia
-
92
New pharmaceutical partnerships
Roche is one of the largest producers of biotechnological medicines for the treatment of oncological, autoimmune, infectious, and ophthalmological diseases and disorders of the central nervous system.
The company is also one of the leaders in the field of in-vitro diagnostics and histological diagnostics of oncological diseases, as well as a pioneer in the field of self-control of diabetes mellitus.
Roche companies and TeamIdea started working together on a joint project to implement Russian localization as part of the Russian Add-On package in 2018.